FDA Inspection 1008344 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - March 20, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany, with an inspection on March 20, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany
Inspection Date: March 20, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 9a730984-8411-4cbd-89ee-7407053ace5a